Drug intelligence / Profile preview

bupivacaine hydrochloride + lidocaine hydrochloride + povidone-iodine + triamcinolone

Development stage
Unknown
Modality
Small Molecules
Administration
Topical, Intradermal, Epidural, Intraarticular, Parenteral
01

Overview

**Bupivacaine hydrochloride + lidocaine hydrochloride + povidone-iodine + triamcinolone** is a multi-component compounded procedural drug kit containing two amide local anesthetics, the corticosteroid triamcinolone, and the antiseptic povidone-iodine. Bupivacaine and lidocaine reversibly inhibit voltage-gated sodium channels in peripheral nerves, suppressing impulse conduction and producing local or regional anesthesia and analgesia. Triamcinolone activates glucocorticoid receptors to reduce inflammatory signaling, while povidone-iodine provides broad topical antimicrobial activity through iodine-mediated oxidative and iodinating effects on microbial cellular components. Products listed under names including BLT-25 KIT, MLK F4 KIT, and P-CARE K40MX/K80MX are compounded, unapproved combination products; the FDA has not found these products safe and effective and has not approved their labeling.

Brand names
BLT-25 KITBLT25 KITBLT 25 KITMLK F4 KITP-CARE K40MXP-CARE K80MX
02

Targets

MOR (Mu opioid receptor)NaV (Voltage-gated sodium channels)GR (Glucocorticoid receptor)KCNK2 (Potassium channel subfamily K member 2)Kir (Inward-rectifier potassium channels)

Beyond the preview

Go deeper on bupivacaine hydrochloride + lidocaine hydrochloride + povidone-iodine + triamcinolone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bupivacaine hydrochloride + lidocaine hydrochloride + povidone-iodine + triamcinolone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call